tiprankstipranks
Trending News
More News >
Modern Chinese Medicine Group Co. Ltd. (HK:1643)
:1643
Hong Kong Market

Modern Chinese Medicine Group Co. Ltd. (1643) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Modern Chinese Medicine Group Co. Ltd. has a market cap or net worth of HK$228.00M. The enterprise value is -HK$29.37M.
Market CapHK$228.00M
Enterprise Value-HK$29.37M

Share Statistics

Modern Chinese Medicine Group Co. Ltd. has 600,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding600,000,000
Owned by Insiders
Owned by Institutions

Financial Efficiency

Modern Chinese Medicine Group Co. Ltd.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 2.97%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)2.97%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee1.13M
Profits Per Employee77.99K
Employee Count190
Asset Turnover0.40
Inventory Turnover5.20

Valuation Ratios

The current PE Ratio of Modern Chinese Medicine Group Co. Ltd. is 21.85. Modern Chinese Medicine Group Co. Ltd.’s PEG ratio is -0.34.
PE Ratio21.85
PS Ratio0.00
PB Ratio0.41
Price to Fair Value0.44
Price to FCF-5.00
Price to Operating Cash Flow2.69
PEG Ratio-0.34

Income Statement

In the last 12 months, Modern Chinese Medicine Group Co. Ltd. had revenue of 214.07M and earned 9.67M in profits. Earnings per share was 0.02.
Revenue214.07M
Gross Profit55.20M
Operating Income22.33M
Pretax Income14.82M
Net Income9.67M
EBITDA29.82M
Earnings Per Share (EPS)0.02

Cash Flow

In the last 12 months, operating cash flow was 74.36M and capital expenditures -114.39M, giving a free cash flow of -40.03M billion.
Operating Cash Flow74.36M
Free Cash Flow-40.03M
Free Cash Flow per Share-0.07

Dividends & Yields

Modern Chinese Medicine Group Co. Ltd. pays an annual dividend of HK$0.017, resulting in a dividend yield of ―
Dividend Per ShareHK$0.017
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.31
52-Week Price Change15.79%
50-Day Moving Average0.36
200-Day Moving Average0.38
Relative Strength Index (RSI)74.25
Average Volume (3m)1.29M

Important Dates

Modern Chinese Medicine Group Co. Ltd. upcoming earnings date is Aug 21, 2025, TBA (Confirmed).
Last Earnings DateMar 26, 2025
Next Earnings DateAug 21, 2025
Ex-Dividend DateMay 25, 2022

Financial Position

Modern Chinese Medicine Group Co. Ltd. as a current ratio of 7.20, with Debt / Equity ratio of 0.03%
Current Ratio7.20
Quick Ratio6.58
Debt to Market Cap0.00
Net Debt to EBITDA-7.70
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Modern Chinese Medicine Group Co. Ltd. has paid 5.15M in taxes.
Income Tax5.15M
Effective Tax Rate0.35

Enterprise Valuation

Modern Chinese Medicine Group Co. Ltd. EV to EBITDA ratio is -0.61, with an EV/FCF ratio of 0.00.
EV to Sales-0.09
EV to EBITDA-0.61
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00

Balance Sheet

Modern Chinese Medicine Group Co. Ltd. has HK$229.67M in cash and marketable securities with ¥135.00K in debt, giving a net cash position of -HK$229.53M billion.
Cash & Marketable SecuritiesHK$229.67M
Total Debt¥135.00K
Net Cash-HK$229.53M
Net Cash Per Share-HK$0.38
Tangible Book Value Per ShareHK$0.81

Margins

Gross margin is 25.78%, with operating margin of 10.43%, and net profit margin of 4.52%.
Gross Margin25.78%
Operating Margin10.43%
Pretax Margin6.92%
Net Profit Margin4.52%
EBITDA Margin13.93%
EBIT Margin11.13%

Analyst Forecast

The average price target for Modern Chinese Medicine Group Co. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-39.05%
EPS Growth Forecast-80.60%

Scores

Smart Score4
AI Score61
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis